
Archived App (Last seen on 22 Aug 2025)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
This medical app allows patients to report outcome data remotely and more frequently via smartphones. It enhances site-patient interactions and has been shown to improve patient retention and protocol adherence. Data can also be collected from home using IoT devices.
What's New in CliniOps ePRO
3.1.7
April 27, 2022
Minor bug fixes and enhancements
Developer apps
FAQ
What is CliniOps ePRO used for?
CliniOps ePRO is used to engage patients remotely, allowing them to report outcome data more frequently via their smartphones. It aims to improve patient retention and protocol adherence in clinical trials.
Can CliniOps ePRO collect data from IoT devices?
Yes, CliniOps ePRO supports collecting patient data from home via IoT devices if needed, enhancing the scope of remote data collection.
Does CliniOps ePRO integrate with medical devices?
Yes, CliniOps ePRO supports medical device integration with its mobile application, allowing for more comprehensive data capture.
What devices is CliniOps ePRO available on?
CliniOps ePRO is available on iPhone, iPad, and iPod devices, offering flexibility for patient use.
What is the age rating for CliniOps ePRO?
CliniOps ePRO has an age rating of 12+, making it suitable for adolescent and adult participants in clinical studies.
How often is CliniOps ePRO updated?
The latest version of CliniOps ePRO is 3.1.7, which was last updated on April 27, 2022. This indicates a history of updates and maintenance.
What is the user rating for CliniOps ePRO?
CliniOps ePRO has a perfect rating of 5.0 stars based on one review, suggesting a highly positive initial user experience.
Does CliniOps ePRO have ads?
No, CliniOps ePRO does not contain advertisements. The app is free to download and use without any ad interruptions.



